Gallium-67 imaging in the management of Hodgkin's disease and other malignant lymphomas.
Gallium-67 imaging is useful in the management of patients with malignant lymphoma, despite its obvious limitations. Data currently in the literature regarding the detectability of sites of lymphoma by 67Ga imaging should be regarded as representing the minimum that can be expected from the method, since all reported series are based on outmoded imaging techniques. The detectability of disease sites appears to vary with tumor histology and anatomic location. Gallium-67 imaging is most useful in following patients after treatment. However, it may justifiably play an important role in the initial staging of lymphoma if the prior probability of disease in the abdomen is low. Lymphoma in abdominal lymph node sites is at least as detectable by 67Ga imaging as by lymphangiography.
D000008:Abdominal Neoplasms / Q000000981:diagnostic imaging; D000328:Adult; D000368:Aged; D001706:Biopsy; D005069:Evaluation Studies as Topic; D005189:False Positive Reactions; D005260:Female; D005710:Gallium Radioisotopes; D006689:Hodgkin Disease / Q000000981:diagnostic imaging* / Q000473:pathology; D006801:Humans; D007089:Image Enhancement; D008223:Lymphoma / Q000000981:diagnostic imaging* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010386:Pelvic Neoplasms / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D013899:Thoracic Neoplasms / Q000000981:diagnostic imaging; D014054:Tomography
D005710:Gallium Radioisotopes